JonathanSchwartzMDFACC, FSCAI

Cardiology • Charlotte, NC

Adult Congenital Heart Disease, Interventional Cardiology

Structural Interventional Cardiologist

Join to view full profile

Dr. Schwartz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schwartz's full profile

Already have an account?

Office
1237 Harding Pl
Ste 3100
Charlotte, NC 28204
Phone+1 704-373-0212

Education & Training

University of ColoradoChief Residency, Internal Medicine, 2012
Abbott-Northwestern Hospital/Allina Health SystemFellowship, Adult Congenital Heart Disease, 2017 - 2018
Stanford Health Care-Sponsored Stanford UniversityFellowship, Interventional Cardiology, 2016 - 2017
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2013 - 2016
University of ColoradoResidency, Internal Medicine, 2010 - 2012
University of ColoradoInternship, Internal Medicine, 2009 - 2010
University of Minnesota Medical SchoolClass of 2009

Certifications & Licensure

CA State Medical License 2013 - Present
SC State Medical License 2020 - 2025
NC State Medical License 2018 - 2024
MN State Medical License 2016 - 2018
CO State Medical License 2011 - 2015
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Publications & Presentations

PubMed

25 citations
Invasive assessment of myocardial bridging in patients with angina and no obstructive coronary artery disease.
Vedant S. Pargaonkar, Takumi Kimura, Ryo Kameda, Shigemitsu Tanaka, Ryotaro Yamada
Eurointervention. 2021-01-20
19 citations
Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process.
Jonathan G. Schwartz, Uday N. Kumar, Dan E. Azagury, Todd J. Brinton, Paul G. Yock
JACC. Basic to Translational Science. 2016-10-31
49 citations
Increased Coronary Artery Plaque Volume Among Male Marathon Runners.
Robert S. Schwartz, Stacia Merkel Kraus, Jonathan G. Schwartz, Kelly Wickstrom, Gretchen Peichel
Missouri Medicine. 2014-03-01

Press Mentions

Evidence of TAVR Benefit Extends to Cardiogenic ShockMay 18th, 2023
AFib Patients Better off with No Antiplatelet After TAVRMarch 29th, 2020
Rocket Pharmaceuticals Presents Preclinical Data of RP-A501 for Danon Disease at the American Society of Gene and Cell Therapy 2019 Annual MeetingMay 2nd, 2019
Join now to see all